Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.
Toxicol Sci. 2011 Mar;120 Suppl 1(Suppl 1):S28-48. doi: 10.1093/toxsci/kfq283. Epub 2010 Sep 29.
Since their discovery 50 years ago, the aflatoxins have become recognized as ubiquitous contaminants of the human food supply throughout the economically developing world. The adverse toxicological consequences of these compounds in populations are quite varied because of a wide range of exposures leading to acute effects, including rapid death, and chronic outcomes such as hepatocellular carcinoma. Furthermore, emerging studies describe a variety of general adverse health effects associated with aflatoxin, such as impaired growth in children. Aflatoxin exposures have also been demonstrated to multiplicatively increase the risk of liver cancer in people chronically infected with hepatitis B virus (HBV) illustrating the deleterious impact that even low toxin levels in the diet can pose for human health. The public health impact of aflatoxin exposure is pervasive. Aflatoxin biomarkers of internal and biologically effective doses have been integral to the establishment of the etiologic role of this toxin in human disease through better estimates of exposure, expanded knowledge of the mechanisms of disease pathogenesis, and as tools for implementing and evaluating preventive interventions.
自 50 年前发现以来,黄曲霉毒素已被公认为经济欠发达国家人类食物供应中无处不在的污染物。由于暴露范围广泛,导致急性效应(包括迅速死亡)和慢性后果(如肝细胞癌),这些化合物对人群的不良毒理学后果差异很大。此外,新出现的研究描述了与黄曲霉毒素相关的多种一般健康不良影响,例如儿童生长受损。暴露于黄曲霉毒素还被证明会使慢性乙型肝炎病毒(HBV)感染人群的肝癌风险呈倍数增加,这说明了即使饮食中的毒素水平很低,也会对人类健康造成有害影响。黄曲霉毒素暴露的公共卫生影响是普遍存在的。黄曲霉毒素的内暴露和生物有效剂量生物标志物是通过更好地估计暴露、扩大对疾病发病机制的了解以及作为实施和评估预防干预措施的工具,来确定该毒素在人类疾病中的病因作用的不可或缺的部分。